Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
02096
02096
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
02096 News
SIMCERE PHARMA: Clinical Trials for SIM0610 Greenlit in China
Dec 23 2025
aastocks
SIMCERE PHARMA Enters Exclusive Licensing Deal with Ipsen, Potentially Worth Up to US$1.06 Billion
Dec 22 2025
aastocks
SIMCERE PHARMA's ENZESHU and ENDOSTAR Added to China's National Reimbursement Drug List
Dec 08 2025
aastocks
<Research>BOCOMI Releases November Recommended Chinese Stocks (Table)
Nov 03 2025
aastocks
<Study> UBS Ratings and Target Prices for Chinese Pharmaceuticals (Table)
Sep 30 2025
aastocks
<Research>BOCOMI: Trump's New Tariffs on Imported Innovative Medications Likely to Have Minimal Effect on Chinese Pharmaceutical Companies
Sep 26 2025
aastocks
SIMCERE PHARMA Plans to Generate HKD1.554B Net Through Top-up Placing at an 8% Discount
Sep 02 2025
aastocks
<Research>CICC Expects Commercial Insurance Innovative Drug Catalog Adjustments to Help High-Value Innovative Drugs Land
Aug 13 2025
aastocks
<Research>CICC Ratings, TPs on Medical Health Stocks (Table)
Aug 13 2025
aastocks
Show More News
